CircZXDC Promotes Vascular Smooth Muscle Cell Transdifferentiation via Regulating miRNA-125a-3p/ABCC6 in Moyamoya Disease

Yuan Liu, Yimin Huang, Xincheng Zhang, Xiaopeng Ma, Xuejun He, Chao Gan, Xin Zou, Sheng Wang, Kai Shu, Ting Lei, Huaqiu ZhangCells 2022 · DOI

TL;DR

This study identifies a novel molecular pathway, the circZXDC-miR-125a-3p-ABCC6 axis, that drives vascular smooth muscle cell (VSMC) transdifferentiation, a key process in Moyamoya Disease (MMD) pathology. This axis could serve as a diagnostic biomarker and a therapeutic target for MMD.

What Problem Does This Paper Address?

Moyamoya Disease (MMD) is a serious cerebrovascular condition characterized by the progressive narrowing of major arteries at the base of the brain, leading to recurrent strokes. While genetic mutations (like RNF213) and immune responses are implicated, the precise cellular and molecular mechanisms driving the characteristic thickening of blood vessel walls (neointima) in MMD remain largely unclear. Specifically, how vascular smooth muscle cells (VSMCs) contribute to this pathological thickening is a critical gap in our understanding. This paper aims to unravel a specific molecular pathway that might explain this VSMC involvement and contribute to MMD pathogenesis.

Methods

The researchers employed a multi-pronged approach combining bioinformatics analysis with extensive in vitro experiments:

  • Bioinformatics Analysis: They analyzed public RNA sequencing datasets (circRNA-seq, miRNA-seq, mRNA-seq) from MMD patients and used online tools (CircBank, TargetScan) to predict potential interactions and construct a circRNA-miRNA-mRNA regulatory network.
  • In Vitro Experiments:
    • Cell Culture and Transfection: Human aortic smooth muscle cells (HASMCs) were cultured and manipulated to overexpress or silence specific genes (circZXDC, miR-125a-3p, ABCC6, RNF213) or mimic/inhibit pathways.
  • Functional Assays: * CCK-8 Assay: To assess cell proliferation.
  • Transwell Assay: To measure cell migration.
  • Wound-Healing Assay: To evaluate cell migratory behavior.
  • Molecular Assays: * Dual Luciferase Reporter Assays: To confirm direct binding interactions between circZXDC and miR-125a-3p, and between miR-125a-3p and ABCC6 mRNA.
  • Western Blotting: To detect the expression levels of key proteins involved in VSMC phenotype switching (OPN, VIM, EREG) and endoplasmic reticulum stress (XBP1s, GRP78).
  • RT-qPCR: To quantify the expression levels of circZXDC and miR-125a-3p.
  • Immunohistochemistry (IHC) and Immunofluorescence: To visualize the expression and localization of proteins (ABCC6, α-SMA, XBP1s, p-EIF) in MMD patient tissues and cells.
  • Oxygen-Glucose Deprivation (OGD) Model: Used to mimic the hypoxic microenvironment found in occluded MMD vessels and study its effect on VSMCs.

Datasets

  • Public RNA Sequencing Datasets: circRNA-seq, miRNA-seq, and mRNA-seq data from MMD patients were utilized for network establishment.
  • Clinical Specimens: Blood samples from MMD patients and healthy controls were collected for plasma circZXDC level analysis. STA vessels from MMD and non-MMD patients were used for IHC and immunofluorescence staining.

Key Insights and Ideas

  • circZXDC as a Potential MMD Biomarker: The study found significantly higher levels of circZXDC in the plasma of MMD patients, particularly those with the RNF213 mutation. This suggests circZXDC could be a valuable diagnostic marker for MMD.
  • circZXDC Drives VSMC Synthetic Phenotype: Overexpression of circZXDC in VSMCs promoted a shift towards a "synthetic" phenotype, characterized by increased proliferation and migration. This is crucial because synthetic VSMCs are implicated in the neointima formation seen in MMD.
  • The "Sponge" Mechanism: circZXDC acts as a "molecular sponge" for miR-125a-3p. By binding to miR-125a-3p, circZXDC effectively reduces its availability, leading to increased expression of its target, ABCC6.
  • ABCC6 and Endoplasmic Reticulum Stress (ERS): The study revealed that ABCC6 plays a role in inducing endoplasmic reticulum stress (ERS) in VSMCs. ERS is a cellular stress response that has been linked to VSMC transdifferentiation.
  • RNF213 Mutation Link: The RNF213 mutation, a known MMD susceptibility gene, was associated with higher circZXDC expression, suggesting a potential mechanistic link between this genetic factor and the identified molecular pathway.

Key Results

  • circZXDC Levels: circZXDC was significantly upregulated in MMD patient plasma compared to non-MMD controls, with an AUC > 0.9 for diagnostic potential.
  • VSMC Proliferation and Migration: circZXDC overexpression led to increased VSMC proliferation (CCK-8, Ki-67 staining) and migration (Transwell, wound-healing assays), especially under hypoxic (OGD) conditions.
  • miR-125a-3p Regulation: circZXDC overexpression significantly reduced miR-125a-3p levels. Conversely, miR-125a-3p treatment attenuated circZXDC-induced VSMC proliferation, migration, and synthetic phenotype switch.
  • ABCC6 Expression: circZXDC overexpression upregulated ABCC6 expression, an effect that was reversed by miR-125a-3p treatment. ABCC6 was also found to be upregulated in MMD vessels.
  • ERS Involvement: MMD vessels showed increased markers of ERS. ABCC6 deficiency attenuated OGD-induced ERS, and ABCC6 overexpression exacerbated the VSMC synthetic phenotype switch, which could be rescued by an ERS inhibitor (4-PBA).
  • Correlation: ABCC6 expression positively correlated with ERS markers (XBP1s) and intima thickness in MMD vessels.

Limitations and Future Work

  • In Vitro Focus: The study primarily relies on in vitro experiments. The authors acknowledge that further animal experiments are necessary to validate these findings in a more complex biological system.
  • Prognostic Value: While circZXDC showed diagnostic potential, the study was limited in its ability to verify its prognostic value due to insufficient data.
  • RNF213 Mechanism: The precise mechanisms by which RNF213 influences circZXDC expression require further detailed investigation.
  • Therapeutic Potential: The authors suggest that circZXDC might be a diagnostic biomarker and that an ABCC6-specific inhibitor could be a promising therapeutic option for MMD, highlighting the need for further drug development and testing.

Summary updated

Abstract

Moyamoya disease (MMD) is an occlusive, chronic cerebrovascular disease affected by genetic mutation and the immune response. Furthermore, vascular smooth muscle cells (VSMCs) and endothelial cells (ECs) participate in the neointima of MMD, but the etiology and pathophysiological changes in MMD vessels remain largely unknown. Therefore, we established the circZXDC (ZXD family zinc finger C)-miR-125a-3p-ABCC6 (ATP-binding cassette subfamily C member 6) axis from public datasets and online tools based on "sponge-like" interaction mechanisms to investigate its possible role in VSMCs. The results from a series of in vitro experiments, such as dual luciferase reporter assays, cell transfection, CCK-8 assays, Transwell assays, and Western blotting, indicate a higher level of circZXDC in the MMD plasma, especially in those MMD patients with the RNF213 mutation. Moreover, circZXDC overexpression results in a VSMC phenotype switching toward a synthetic status, with increased proliferation and migration activity. CircZXDC sponges miR-125a-3p to increase ABCC6 expression, which induces ERS (endoplasmic reticulum stress), and subsequently regulates VSMC transdifferentiation from the contractive phenotype to the synthetic phenotype, contributing to the intima thickness of MMD vessels. Our findings provide insight into the pathophysiological mechanisms of MMD and indicate that the circZXDC-miR-125a-3p-ABCC6 axis plays a pivotal role in the progression of MMD. Furthermore, circZXDC might be a diagnostic biomarker and an ABCC6-specific inhibitor and has the potential to become a promising therapeutic option for MMD.
BibTeX
@inproceedings{liu2022circzxdc,
  author = {Yuan Liu and Yimin Huang and Xincheng Zhang and Xiaopeng Ma and Xuejun He and Chao Gan and Xin Zou and Sheng Wang and Kai Shu and Ting Lei and Huaqiu Zhang},
  title = {{CircZXDC Promotes Vascular Smooth Muscle Cell Transdifferentiation via Regulating miRNA-125a-3p/ABCC6 in Moyamoya Disease}},
  booktitle = {Cells},
  year = {2022},
  doi = {10.3390/cells11233792},
}
Figure